Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate 8 mg/1 (Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate TABLET) 8 mg/1

Buprenorphine hydrochloride and naloxone hydrochloride dihydrate 8 mg/1 sublingual tablets for opioid dependence management. Learn about uses, effects, and precautions.

Strength

8 mg/1

Pack Size

30 TABLET in 1 BOTTLE (0054-0189-13)

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Buprenorphine hydrochloride and naloxone hydrochloride dihydrate tablets are commonly used in the treatment of opioid dependence. This combination medication helps manage withdrawal symptoms and cravings associated with opioid addiction. It is often prescribed as part of a comprehensive treatment plan that includes counseling and behavioral therapies. The primary use of this medication is to support individuals in their journey towards recovery from opioid dependence.

Side Effects

Common effects of buprenorphine hydrochloride and naloxone hydrochloride dihydrate may include dizziness, nausea, and constipation. Some individuals may experience headaches or fatigue. These effects can vary from person to person and may subside as the body adjusts to the medication. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

Buprenorphine hydrochloride and naloxone hydrochloride dihydrate should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored securely to prevent misuse. Individuals with a history of liver disease or respiratory issues should inform their healthcare provider before starting this medication.

Avoid Interactions

Buprenorphine hydrochloride and naloxone hydrochloride dihydrate may interact with other medications, including sedatives, antidepressants, and certain pain relievers. Alcohol consumption should be avoided while taking this medication, as it can increase the risk of side effects. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

References

Frequently Asked Questions

This medication is primarily used for the treatment of opioid dependence. It helps manage withdrawal symptoms and cravings.

These tablets are designed to be placed under the tongue and allowed to dissolve. They should not be swallowed or chewed.

Common side effects may include dizziness, nausea, constipation, headaches, and fatigue.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

This medication should be stored securely, out of reach of children and pets, and at room temperature.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.